Heart medications are an essential part of life for millions of people, particularly those who have dealt with heart failure and/or those who suffer from irregular heartbeats. The demand for these medications is at an all-time high, and drug companies are churning out new medications and higher volumes of these medications than ever before.
Unfortunately, a hyper-speed market can lead to problems, and that appears to be the case with one form of heart medication sold under several names, all of which have recently been recalled by the companies responsible. The danger posed by a consistent manufacturing defect is particularly high for those patients with renal failure, and each of the components of this issue is detailed below.
The drugs are sold under different brand names, but they are essentially the same product with a similar active ingredient. They are as follows:
The Companies that make Anti-Coagulants:
The companies responsible for either manufacturing these drugs or distributing them appear below:
- Actavis Totowa LLC – Digitek
- Mylan Pharmaceuticals, Inc. – Bertek
- UDL Laboratories, Inc. – UDL
The Digitalis Toxicity Condition:
While the companies and brand names may be different, the problem is consistent. Essentially, some of the pills that are manufactured are being released with twice the thickness that they should have, which means that unsuspecting patients are taking twice the dose as intended. When this happens, a condition known as digitalis toxicity results, which is presented by symptoms that include:
- Low Blood Pressure
This is an extremely dangerous condition, which is why these drugs are being pulled from the market. If you have suffered as a result of using these drugs, contact a Digitek attorney immediately.